Grace Therapeutics, Inc. (GRCE) AI Dilution Summary

Cash was $13,756,000 at 2026-06-30 against estimated monthly burn of $1,073,667. The most recent capital raised was an unregistered private placement that closed 2026-08-06, placed by Craig-Hallum Capital Group LLC: 4,761,904 shares at $2.10 per share, for $9,999,998 gross and $9,100,000 net. Every instrument stated here carries a fixed contractual price.